Skip to main content
Advertisement

Main menu

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Other Publications
    • ajnr

User menu

  • Alerts
  • Log in

Search

  • Advanced search
American Journal of Neuroradiology
American Journal of Neuroradiology

American Journal of Neuroradiology

ASHNR American Society of Functional Neuroradiology ASHNR American Society of Pediatric Neuroradiology ASSR
  • Alerts
  • Log in

Advanced Search

  • Home
  • Content
    • Current Issue
    • Accepted Manuscripts
    • Article Preview
    • Past Issue Archive
    • AJNR Case Collection
    • Case of the Week Archive
    • Classic Case Archive
    • Case of the Month Archive
  • Special Collections
    • Spinal CSF Leak Articles (Jan 2020-June 2024)
    • 2024 AJNR Journal Awards
    • Most Impactful AJNR Articles
  • Multimedia
    • AJNR Podcast
    • AJNR Scantastics
    • Video Articles
  • For Authors
    • Submit a Manuscript
    • Author Policies
    • Fast publishing of Accepted Manuscripts
    • Graphical Abstract Preparation
    • Manuscript Submission Guidelines
    • Imaging Protocol Submission
    • Submit a Case for the Case Collection
  • About Us
    • About AJNR
    • Editorial Board
  • More
    • Become a Reviewer/Academy of Reviewers
    • Subscribers
    • Permissions
    • Alerts
    • Feedback
    • Advertisers
    • ASNR Home
  • Follow AJNR on Twitter
  • Visit AJNR on Facebook
  • Follow AJNR on Instagram
  • Join AJNR on LinkedIn
  • RSS Feeds

Welcome to the new AJNR, Updated Hall of Fame, and more. Read the full announcements.


AJNR is seeking candidates for the position of Associate Section Editor, AJNR Case Collection. Read the full announcement.

 

OtherHEAD & NECK

Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Radiologic-Pathologic Correlation with MR Imaging Including Diffusion-Weighted Imaging

H. Kato, M. Kanematsu, K. Mizuta, Y. Ito and Y. Hirose
American Journal of Neuroradiology May 2008, 29 (5) 865-867; DOI: https://doi.org/10.3174/ajnr.A0974
H. Kato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
M. Kanematsu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. Mizuta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Ito
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Y. Hirose
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF
Loading

Abstract

SUMMARY: We present 4 cases of carcinoma ex pleomorphic adenoma of the parotid gland. In 3 of the 4 cases, diffusion-weighted and apparent diffusion coefficient (ADC) mapping images clearly revealed carcinoma as a hypercellular area with low ADC values and pleomorphic adenoma as a hypocellular area with high ADC values. Diffusion-weighted images demonstrated well complex tissue components in carcinoma ex pleomorphic adenoma, which may be useful for the diagnosis of this disease.

Pleomorphic adenoma is a common neoplasm that arises from the major salivary glands and infrequently undergoes malignant transformation. Malignant changes in pleomorphic adenoma have been associated with a long duration, tumor recurrence, radiation therapy, an advanced age, and tumor size. Because the incidence of malignancy is correlated with the duration of pleomorphic adenoma, the risk of developing malignancy is only about 1.5% for a duration of <5 years but increases to 9.5% for a duration of >15 years.1 Carcinoma ex pleomorphic adenoma is an infrequent aggressive malignancy that is believed to evolve from a pre-existing benign adenoma. It accounts for 3.6% (range, 0.9%–14%) of all salivary neoplasms and for 11.7% (range, 2.8%–42.4%) of salivary malignancies.2 Meanwhile, the imaging findings of carcinoma ex pleomorphic adenoma are often nonspecific and are not precisely differentiated from those of other benign and malignant salivary gland tumors. Here, we describe the imaging findings of 4 patients with carcinoma ex pleomorphic adenoma of the parotid gland and correlate these with pathologic findings. Furthermore, we discuss MR imaging diagnostic clues in carcinoma ex pleomorphic adenoma of the parotid gland.

Case Reports

MR Imaging

MR imaging was performed by using a 1.5T MR imaging system (Intera Achieva 1.5T. Pulsar; Philips Medical Systems, Best, the Netherlands) with parallel imaging capability (referred to as sensitivity encoding). Axial diffusion-weighted (5000–5100/70–72 [TR/TE], 256 × 256 matrix) images were obtained by using a single-shot spin-echo echo-planar imaging sequence with a section thickness of 4 mm, without an intersection gap, in all patients. The sequence was executed with 2 values of motion-probing gradients (b = 0 and 1000 s/mm2).

Case 1

A 48-year-old woman felt a slowly enlarging right parotid gland for 5 years. The parotid mass was painless without facial nerve paralysis. T2-weighted images exhibited the 35 × 25 mm mass in a well-demarcated area of heterogeneous intensity (Fig 1A). The lateral component showed mild high intensity; the intermediate component, low intensity; and the medial component, extremely high intensity on T2-weighted images. Diffusion-weighted and apparent diffusion coefficient (ADC) mapping images revealed the lateral component as hypercellular and the intermediate and medial components as hypocellular (Fig 1B). A histopathologic examination of the surgical specimen documented pleomorphic adenoma and an epithelial malignancy, like myoepithelial carcinoma. The lateral component was documented as carcinoma; the intermediate component, as pleomorphic adenoma with marked fibrosis; and the medial component, as pleomorphic adenoma with a marked chondroid matrix.

Fig 1.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 1.

A 48-year-old woman with a carcinoma ex pleomorphic adenoma (case 1). A, Axial T2-weighted image (fast spin-echo: TR/TE, 4102/90) shows a well-demarcated mass with heterogeneous intensity of the right parotid gland. The lateral component shows mild high intensity (arrow), the intermediate component shows low intensity (arrowhead), and the medial component shows extremely high intensity (curved arrow). B, ADC mapping image shows the lateral component of hypercellularity with carcinoma (arrow) and the intermediate and medial component of hypocellularity with pleomorphic adenoma (curved arrow).

Case 2

A 76-year-old man had a painless mass in the right parotid gland for 50 years and had undergone surgical resection twice. The residual tumor had grown rapidly during the prior 6 months. The recurrent tumor was painless with facial nerve paralysis. T2-weighted images exhibited the 52 × 47 mm mass as a well-demarcated area of heterogeneous intensity (Fig 2A). The anterior component showed mild high intensity, and the margins of the posterior component showed low intensity on T2-weighted images. Diffusion-weighted and ADC mapping images revealed the anterior component as hypercellular and the posterior component as hypocellular (Fig 2B). The posterior component showed punctuate calcifications on CT. A histopathologic examination of the surgical specimen revealed pleomorphic adenoma and an epithelial malignancy, such as adenosquamous carcinoma or mucoepidermoid carcinoma. The posterior component was documented as pleomorphic adenoma with fibrosis, hyaline degeneration, and calcification; and the anterior component, as carcinoma with infiltration beyond the capsule.

Fig 2.
  • Download figure
  • Open in new tab
  • Download powerpoint
Fig 2.

A 76-year-old man with a carcinoma ex pleomorphic adenoma (case 2). A, Axial T2-weighted image (fast spin-echo: TR/TE, 4102/90) shows a mainly well-demarcated mass with heterogeneous intensity of the right parotid gland. The anterior component shows mild high intensity (arrowheads), and the margin of the posterior component shows low intensity (arrow). B, ADC mapping image shows the anterior component of hypercellularity with carcinoma (arrowheads) and the posterior component of hypocellularity with pleomorphic adenoma (arrow).

Case 3

An 80-year-old man presented with a painless mass in the right parotid gland of 30 years' duration. However, the mass had shown sudden rapid growth during the prior 3 months and had become painful, with facial nerve paralysis. T2-weighted images exhibited the 35 × 33 mm mass as a well-demarcated area of heterogeneous intensity. The anterior component showed low intensity; and the posterior component, mild-to-moderate high intensity on T2-weighted images. Diffusion-weighted and ADC mapping images revealed the anterior component as hypocellular and the posterior component as hypercellular. The anterior component showed scattered calcifications on CT. A histopathologic examination of the surgical specimen revealed pleomorphic adenoma and an epithelial malignancy (eg, adenocarcinoma, squamous cell carcinoma, or mucoepidermoid carcinoma). The anterior component was documented as pleomorphic adenoma with fibrosis and calcification; and the posterior component, as carcinoma with infiltration beyond the capsule.

Case 4

A 70-year-old woman presented with a painless mass in the left parotid gland of 5 years' duration. Facial nerve paralysis had been felt for 6 months and had gradually progressed. T2-weighted images exhibited the 38 × 20 mm mass as a well-demarcated area of heterogeneous intensity. T2-weighted images showed fairly mixed signal intensity. Hypercellular and hypocellular areas coexisted in a complicated manner on diffusion-weighted and ADC mapping images, and internal hemorrhage was revealed on T1-weighted images. The mass showed necrosis and punctuate calcifications on contrast-enhanced CT. A histopathologic examination of the surgical specimen revealed pleomorphic adenoma and epithelial malignancy with adenocarcinoma. The pleomorphic adenoma portion contained calcifications; and the adenocarcinoma portion, severe hemorrhage and necrosis.

Discussion

According to the World Health Organization histologic classification published in 2005, malignant derivatives of pleomorphic adenomas of salivary gland origin, so called “malignant mixed tumors,” should be divided into 3 different clinical and histologic entities: 1) carcinoma ex pleomorphic adenoma (carcinoma in pre-existing pleomorphic adenoma), 2) carcinosarcoma (true malignant mixed tumor), and 3) metastasizing pleomorphic adenoma. Most malignant mixed tumors are carcinoma ex pleomorphic adenoma, whereas the latter 2 types are extremely unusual.

The typical clinical presentation in a patient with carcinoma ex pleomorphic adenoma is a longstanding history (average, 10–15 years) of pleomorphic adenoma and a sudden period of rapid growth (average, 3–6 months). Pain and facial nerve paralysis are often present. Carcinoma ex pleomorphic adenoma usually is a more poorly circumscribed mass than benign pleomorphic adenoma; is most likely to occur within the major salivary glands, especially the parotid gland; and typically occurs in patients in the sixth-to-eighth decades of life.

Salivary gland tumors have been reported to have the following MR imaging findings3–4: an irregular tumor margin, signal-intensity heterogeneity, tumor infiltration into surrounding tissue, and low signal intensity on T2-weighted images. On the other hand, pleomorphic adenomas often show heterogeneous low-to-intermediate signal intensity on T1-weighted images and intermediate-to-high signal intensity on T2-weighted images. Because pleomorphic adenomas show a variety of signal intensities, which reflect their cytomorphologic and architectural variabilities, it is often difficult to distinguish pleomorphic adenomas from low-grade malignant tumors in the absence of an irregular margin or infiltration into the surrounding tissue. Preoperative radiologic diagnosis by conventional MR imaging of carcinoma ex pleomorphic adenoma containing complicated tissue components remains a challenge for radiologists.

Preoperatively, we have diagnosed malignant salivary gland tumor in case 4 by conventional MR imaging without diffusion-weighted images because hemorrhage and necrosis were evident. Meanwhile, in the other cases, hemorrhage, necrosis, irregular margins, or infiltration into surrounding tissue beyond the fibrous capsule were not obvious, and the differentiation of benignity and malignancy was difficult by conventional MR imaging alone. A previous article reported that the ADC values of pleomorphic adenoma are generally higher than those of malignant salivary gland tumors.5 In 3 of the described cases (other than case 4), malignancy was suggested on the basis of the findings of diffusion-weighted and ADC mapping images (ie, carcinomas were visualized as hypercellular areas with low ADC values; and pleomorphic adenomas, as hypocellular areas with high ADC values). However, because necrosis in carcinomas is visualized as hypocellularity with high ADC values, comparative evaluations by using contrast-enhanced CT may be necessary.

In conclusion, the MR imaging findings of carcinoma ex pleomorphic adenoma are not specific because of the coexistence of different tissue types. Nevertheless, diffusion-weighted images enable tissue characterization at the microscopic level by revealing the various tissue components in carcinoma ex pleomorphic adenoma, which allows the differentiation of benign and malignant salivary tumors. Thus, we recommend including diffusion-weighted and ADC mapping imaging in MR imaging protocols of the salivary gland to facilitate the differentiation of salivary gland tumors.

References

  1. ↵
    Seifert G. Histopathology of malignant salivary gland tumours. Eur J Cancer B Oral Oncol 1992;28:49–56
    CrossRef
  2. ↵
    Olsen KD, Lewis JE. Carcinoma ex pleomorphic adenoma: a clinicopathologic review. Head Neck 2001;23:705–12
    CrossRefPubMed
  3. ↵
    Joe VQ, Westesson PL. Tumors of the parotid gland: MR imaging characteristics of various histologic types. AJR Am J Roentgenol 1994;163:433–38
    PubMed
  4. ↵
    Freling NJ, Molenaar WM, Vermey A, et al. Malignant parotid tumors: clinical use of MR imaging and histologic correlation. Radiology 1992;185:691–96
    PubMed
  5. ↵
    Motoori K, Yamamoto S, Ueda T, et al. Inter- and intratumoral variability in magnetic resonance imaging of pleomorphic adenoma: an attempt to interpret the variable magnetic resonance findings. J Comput Assist Tomogr 2004;28:233–46
    CrossRefPubMed
  • Received November 27, 2007.
  • Accepted after revision December 7, 2007.
  • Copyright © American Society of Neuroradiology
View Abstract
PreviousNext
Back to top

In this issue

American Journal of Neuroradiology: 29 (5)
American Journal of Neuroradiology
Vol. 29, Issue 5
May 2008
  • Table of Contents
  • Index by author
Advertisement
Print
Download PDF
Email Article

Thank you for your interest in spreading the word on American Journal of Neuroradiology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Radiologic-Pathologic Correlation with MR Imaging Including Diffusion-Weighted Imaging
(Your Name) has sent you a message from American Journal of Neuroradiology
(Your Name) thought you would like to see the American Journal of Neuroradiology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Cite this article
H. Kato, M. Kanematsu, K. Mizuta, Y. Ito, Y. Hirose
Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Radiologic-Pathologic Correlation with MR Imaging Including Diffusion-Weighted Imaging
American Journal of Neuroradiology May 2008, 29 (5) 865-867; DOI: 10.3174/ajnr.A0974

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
0 Responses
Respond to this article
Share
Bookmark this article
Carcinoma Ex Pleomorphic Adenoma of the Parotid Gland: Radiologic-Pathologic Correlation with MR Imaging Including Diffusion-Weighted Imaging
H. Kato, M. Kanematsu, K. Mizuta, Y. Ito, Y. Hirose
American Journal of Neuroradiology May 2008, 29 (5) 865-867; DOI: 10.3174/ajnr.A0974
del.icio.us logo Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Purchase

Jump to section

  • Article
    • Abstract
    • Case Reports
    • Discussion
    • References
  • Figures & Data
  • Info & Metrics
  • Responses
  • References
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • MR Imaging Findings of Carcinoma Ex Pleomorphic Adenoma Related to Extracapsular Invasion and Prognosis
  • Crossref (70)
  • Google Scholar

This article has been cited by the following articles in journals that are participating in Crossref Cited-by Linking.

  • Carcinoma ex Pleomorphic Adenoma: A Comprehensive Review of Clinical, Pathological and Molecular Data
    Joyce Antony, Vinod Gopalan, Robert A. Smith, Alfred K. Y. Lam
    Head and Neck Pathology 2012 6 1
  • State-of-the-Art Imaging of Salivary Gland Tumors
    Ahmed Abdel Khalek Abdel Razek, Suresh K. Mukherji
    Neuroimaging Clinics of North America 2018 28 2
  • Salivary Glands: Echo-Planar versus PROPELLER Diffusion-weighted MR Imaging for Assessment of ADCs
    Chun-Jung Juan, Hing-Chiu Chang, Chun-Jen Hsueh, Hua-Shan Liu, Yin-Cheng Huang, Hsiao-Wen Chung, Cheng-Yu Chen, Hung-Wen Kao, Guo-Shu Huang
    Radiology 2009 253 1
  • Multiparametric magnetic resonance imaging of parotid tumors: A systematic review
    H. Coudert, S. Mirafzal, A. Dissard, L. Boyer, P.-F. Montoriol
    Diagnostic and Interventional Imaging 2021 102 3
  • Review of the Major and Minor Salivary Glands, Part 2: Neoplasms and Tumor-like Lesions
    Alexander T Kessler, Alok A Bhatt
    Journal of Clinical Imaging Science 2018 8
  • Imaging for Head and Neck Cancer
    Jesty Abraham
    Surgical Oncology Clinics of North America 2015 24 3
  • MRI criteria for the diagnosis of pleomorphic adenoma: a validation study
    Soroush Zaghi, Leenoy Hendizadeh, Tony Hung, Salar Farahvar, Elliot Abemayor, Ali R. Sepahdari
    American Journal of Otolaryngology 2014 35 6
  • Stiffness of salivary gland and tumor measured by new ultrasonic techniques: Virtual touch quantification and IQ
    Takashi Matsuzuka, Masahiro Suzuki, Satoshi Saijo, Masakazu Ikeda, Takamichi Matsui, Yukio Nomoto, Mika Nomoto, Mitsuyoshi Imaizumi, Yasuhiro Tada, Koichi Omori
    Auris Nasus Larynx 2015 42 2
  • Pitfalls in the Staging of Cancer of the Major Salivary Gland Neoplasms
    Elliott R. Friedman, Amit M. Saindane
    Neuroimaging Clinics of North America 2013 23 1
  • Cystic lesions of the parotid gland: radiologic-pathologic correlation according to the latest World Health Organization 2017 Classification of Head and Neck Tumours
    Hirotaka Takita, Tohru Takeshita, Taro Shimono, Hiroko Tanaka, Hiroyoshi Iguchi, Shigeo Hashimoto, Yuko Kuwae, Masahiko Ohsawa, Yukio Miki
    Japanese Journal of Radiology 2017 35 11

More in this TOC Section

  • WHO Classification Update: Nasal&Skull Base Tumors
  • Peritumoral Signal in Vestibular Schwannomas
  • Chondrosarcoma vs Synovial Chondromatosis: Imaging
Show more HEAD & NECK

Similar Articles

Advertisement

Indexed Content

  • Current Issue
  • Accepted Manuscripts
  • Article Preview
  • Past Issues
  • Editorials
  • Editors Choice
  • Fellow Journal Club
  • Letters to the Editor

Cases

  • Case Collection
  • Archive - Case of the Week
  • Archive - Case of the Month
  • Archive - Classic Case

Special Collections

  • Special Collections

Resources

  • News and Updates
  • Turn around Times
  • Submit a Manuscript
  • Author Policies
  • Manuscript Submission Guidelines
  • Evidence-Based Medicine Level Guide
  • Publishing Checklists
  • Graphical Abstract Preparation
  • Imaging Protocol Submission
  • Submit a Case
  • Become a Reviewer/Academy of Reviewers
  • Get Peer Review Credit from Publons

Multimedia

  • AJNR Podcast
  • AJNR SCANtastic
  • Video Articles

About Us

  • About AJNR
  • Editorial Board
  • Not an AJNR Subscriber? Join Now
  • Alerts
  • Feedback
  • Advertise with us
  • Librarian Resources
  • Permissions
  • Terms and Conditions

American Society of Neuroradiology

  • Not an ASNR Member? Join Now

© 2025 by the American Society of Neuroradiology All rights, including for text and data mining, AI training, and similar technologies, are reserved.
Print ISSN: 0195-6108 Online ISSN: 1936-959X

Powered by HighWire